Salamat, Hasmina C.
HRN: 28-03-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/30/2025
12/06/2025
IV
500mg
Q8H
For Open Cholecstectomy
Checking Initial Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines